Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan. | JAMA Netw Open | 2021 | 33822065 | PubTator, text mining | PubMed |
| Göttingen Minipigs as a Model to Evaluate Longevity, Functionality, and Memory of Immune Response Induced by Pertussis Vaccines. | Front Immunol | 2021 | 33815369 | PubTator, text mining | PubMed |
| Connection of BANK1, Tolerance, Regulatory B cells, and Apoptosis: Perspectives of a Reductionist Investigation. | Front Immunol | 2021 | 33815360 | PubTator, text mining | PubMed |
| Covalent Cysteine Targeting of Bruton's Tyrosine Kinase (BTK) Family by Withaferin-A Reduces Survival of Glucocorticoid-Resistant Multiple Myeloma MM1 Cells. | Cancers (Basel) | 2021 | 33807411 | PubTator, text mining | PubMed |
| Bleeding by Bruton Tyrosine Kinase-Inhibitors: Dependency on Drug Type and Disease. | Cancers (Basel) | 2021 | 33806595 | PubTator, text mining | PubMed |
| Ophthalmologic Manifestations of Primary Sjögren's Syndrome. | Genes (Basel) | 2021 | 33806489 | PubTator, text mining | PubMed |
| NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma. | Cancers (Basel) | 2021 | 33805359 | PubTator, text mining | PubMed |
| The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy. | Int J Mol Sci | 2021 | 33802262 | PubTator, text mining | PubMed |
| The evolving role of Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia. | Ther Adv Hematol | 2021 | 33796237 | PubTator, text mining | PubMed |
| How the Discovery of the CD4/CD8-p56lck Complexes Changed Immunology and Immunotherapy. | Front Cell Dev Biol | 2021 | 33791292 | PubTator, text mining | PubMed |
| FUT7 Promotes the Epithelial-Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma. | J Inflamm Res | 2021 | 33790621 | PubTator, text mining | PubMed |
| Synergy and allostery in ligand binding by HIV-1 Nef. | Biochem J | 2021 | 33787846 | PubTator, text mining | PubMed |
| Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects. | Front Cell Dev Biol | 2021 | 33777941 | PubTator, text mining | PubMed |
| Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease. | Eur J Hum Genet | 2021 | 33772158 | PubTator, text mining | PubMed |
| Organic synthesis and anti-influenza A virus activity of cyclobakuchiols A, B, C, and D. | PLoS One | 2021 | 33770117 | PubTator, text mining | PubMed |
| Structural insights into redox-active cysteine residues of the Src family kinases. | Redox Biol | 2021 | 33765616 | PubTator, text mining | PubMed |
| Tunable Methacrylamides for Covalent Ligand Directed Release Chemistry. | J Am Chem Soc | 2021 | 33761747 | PubTator, text mining | PubMed |
| Challenges Involved in Incorporating Personalised Treatment Plan as Routine Care of Patients with Diabetes. | Pharmgenomics Pers Med | 2021 | 33758531 | PubTator, text mining | PubMed |
| Gene Expression Profiling of Apoptotic Proteins in Circulating Peripheral Blood Mononuclear Cells in Type II Diabetes Mellitus and Modulation by Metformin. | Diabetes Metab Syndr Obes | 2021 | 33758522 | PubTator, text mining | PubMed |
| BLK and BANK1 variants and interactions are associated with susceptibility for primary Sjögren's syndrome and with some clinical features. | Cell Immunol | 2021 | 33756160 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=40